🏛️ Enterprise AI Platform & Governance

This section covers corporate investment behaviour of pharmaceutical companies, not the efficacy or safety of any medicinal product. Headlines are quoted as published; no claim about product performance is made or implied by this site. Collection and classification are automated and may misclassify or miss items. Disclaimer

• 2026-09-19
  S4 Amount disclosedByteDance spin-off Anew Labs raises US$290m amid AI drug design fundraising boomUS$290m — South China Morning Post09/18 12:00 JST
• 2026-09-19
  S3 Capital moveNAVER D2SF Invests in AI-Driven Precision Medicine Company ImpriMed — TradingView09/19 00:00 JST
• 2026-09-19
  S2 Deal / Partnership【AI healthcare stocks surge】Anthropic partners with Novo — will AI actually speed up new drug development? — Moomoo09/18 20:38 JSTAnthropic
• 2026-09-19
  S1 DeploymentAnthropic expands use of artificial intelligence in life sciences — Balkanweb.com09/19 01:08 JSTAnthropic
• 2026-09-18
  S4 Amount disclosedTempus AI (TEM) Extends Rally After Earnings Beat And $1.5B Deal$1.5B — StocksToTrade09/18 01:33 JSTTempus AI
• 2026-09-18
  S4 Amount disclosedCognita Imaging Receives $1.29 Million FDA Contract to Test New Approach to Evaluating Generative AI in Radiology$1.29 Million — BioSpace09/17 12:37 JST
• 2026-09-18
  S2 Deal / PartnershipNovo Nordisk deepens its AI push with Anthropic partnership — Baton Rouge Business Report09/17 23:33 JSTNovo NordiskAnthropic
• 2026-09-17
  S4 Amount disclosedByteDance completes $290 million fundraising for AI drug unit after its spin-off, sources say$290 million — whbl.com09/17 00:17 JST
• 2026-09-17
  S4 Amount disclosedTempus AI’s 10.7% Rally Centers on $200 Million of Data-License Bookings$200 Million — TechStock²09/16 20:51 JSTTempus AI
• 2026-09-17
  S3 Capital moveTikTok parent ByteDance raises cash for drug AI spinout Anew — pharmaphorum09/16 21:20 JST
• 2026-09-17
  S2 Deal / PartnershipCan Novo Nordisk’s Anthropic Partnership Drive an AI-Powered Turnaround? — NAI50009/16 22:11 JSTNovo NordiskAnthropic
• 2026-09-17
  S2 Deal / PartnershipNovo partners with Anthropic to speed up drug development with Claude — Yahoo Finance09/16 22:21 JSTAnthropic
• 2026-09-16
  S4 Amount disclosedOpenAI Foundation Gives $125M to Public Data for AI-Driven Health Program$125M — Inside Precision Medicine09/15 22:32 JSTOpenAI
• 2026-09-16
  S3 Capital moveTempus AI (TEM) Jumps As Upgrade, Acquisition Fuel Bullish Momentum — StocksToTrade09/16 01:33 JSTTempus AI
• 2026-09-16
  S1 DeploymentEisai introduces AI conversational role-playing service "Exabase Role-Playing" — PR TIMES09/15 08:30 JST
• 2026-09-16
  S1 DeploymentSTAT+: New documents reveal problems with Medicare’s prior-authorization pilot — STAT News09/15 22:06 JST
• 2026-09-15
  S4 Amount disclosedGraph AI Secures $13.3 Mn Series A To Scale AI Drug Safety Platform$13.3 Mn — BW Disrupt09/14 11:51 JST
• 2026-09-15
  S3 Capital moveSpotlight On: AI drug R&D is pulling venture dollars upstream - and why pharma should care — FirstWord Pharma09/15 00:32 JST
• 2026-09-15
  S1 Deployment医療AIのアイリス、医師向け生成AIツール「Evidence Finder」にて、Sakana AI社の日本語特化LLMを導入 — PR TIMES09/14 11:00 JST
• 2026-09-13
  S4 Amount disclosedFundly.ai Raises $4.9 Million to Expand B2B Pharma Platform$4.9 Million — Whalesbook09/12 22:14 JSTAlso reported by 1: Indian Startup News
• 2026-09-12
  S1 DeploymentOutSee secures £50,000 Innovate UK grant for agentic AI drug target validation pilot — Manufacturing Chemist09/11 20:53 JST
• 2026-09-12
  S1 DeploymentWhy Pharma's Next AI Challenge Is Supervision, Not Adoption — Pharmaceutical Commerce09/11 23:09 JST
• 2026-09-11
  S4 Amount disclosedFundly.ai raises $4 million in pharma distribution funding$4 million — Voice of Healthcare09/10 16:30 JST
• 2026-09-11
  S3 Capital moveDr. Thomas Clozel, Co-founder and CEO of Owkin – Interview Series — Unite.AI09/11 01:13 JSTOwkin
• 2026-09-10
  S4 Amount disclosedMajor Pharma News July–August 2026 | $400B Merger, AI, GLP-1s & India Pharma Updates Ben Stiller (oudY4ulATf)$400B — mshale.com09/09 05:54 JST
• 2026-09-10
  S4 Amount disclosedSTAT+: ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure$62.7 million — STAT News09/10 01:01 JST
• 2026-09-10
  S2 Deal / PartnershipPharma executives sentenced in $92M black-market HIV drug scheme; Trump reveals Rep. Neal Dunn’s serious heart diagnosis; AI model improves accuracy of cardiac ultrasound diagnoses – Morning Medical Update — Medical Economics09/09 18:14 JST
• 2026-09-10
  S1 DeploymentMandi Rollerson Takes on New AI Change and Adoption Leadership Role at Pfizer — hrtoday.in09/09 14:24 JSTPfizer
• 2026-09-10
  S1 DeploymentCiti Survey: Pharma AI Adoption High but Success Rate Expectations Low - News and Statistics — IndexBox09/09 21:53 JST
• 2026-09-10
  S1 DeploymentAI adoption hits 72 percent in pharmaceutical R&D: Citi Research — The Standard (HK)09/09 18:22 JST
• 2026-09-10
  S1 DeploymentVEEV: AI-driven innovation and strong CRM adoption are fueling growth and new opportunities in life sciences — tradingview.com09/10 01:19 JST
• 2026-09-08
  S2 Deal / Partnership2MM: AI Roundup: FDA clears autonomous blood draw robot, UHS acquires Talkspace, Databricks reaches $190 billion valuation, and AI-designed glioblastoma vaccine advances — 2 Minute Medicine09/08 23:04 JST
• 2026-09-08
  S2 Deal / PartnershipSanofi signs three-year partnership with Tricog to scale AI-powered cardiac diagnostics — Indian Pharma Post09/08 01:29 JSTSanofi
• 2026-09-08
  S1 DeploymentOutSee awarded Innovate UK grant for agentic AI pilot study to enhance drug target validation — Cambridge Network09/08 19:05 JST
• 2026-09-07
  S2 Deal / PartnershipOxyContin maker Purdue Pharma set to dissolve after $5B sentence; Mayo Clinic AI detects pancreatic cancer years before diagnosis; results of FDA’s largest-ever infant formula test – Morning Medical Update — Medical Economics09/07 18:37 JST
• 2026-09-07
  S2 Deal / PartnershipYap signs formal contract with Italy's Icarus, to rebuild its AI for handling initial medical facility phone calls for the Japanese market — PR TIMES09/07 10:00 JST
• 2026-09-05
  S1 DeploymentDoes Tempus AI’s (TEM) New ECG-PH Clearance Reveal Its Real Edge In Clinical AI Adoption? — simplywall.st09/05 05:20 JSTTempus AI
• 2026-09-04
  S2 Deal / PartnershipBoehringer Ingelheim signs AI agreement with Owkin — medwatch.com09/04 17:02 JSTBoehringer IngelheimOwkin
• 2026-09-03
  S4 Amount disclosedPharosyn Raises €2.5M for Pharma AI Intelligence Platform.€2.5M — konsulteer.com09/03 15:33 JST
• 2026-09-02
  S4 Amount disclosedSmart toilet, AI platform among tech in use at drugmaker Eli Lilly’s new S$42 million hub in Singapore$42 million — Singapore Economic Development Board (EDB)09/02 16:00 JSTEli Lilly
• 2026-09-02
  S4 Amount disclosedTempus AI Director Nadja West Sells 3,000 Shares for $207,000$207,000 — The Motley Fool09/02 22:35 JSTTempus AI
• 2026-09-02
  S2 Deal / PartnershipBoehringer Signs Deal for Owkin AI, Joining Astra and Sanofi — Bloomberg.com09/02 21:48 JSTSanofiOwkin
• 2026-09-02
  S2 Deal / PartnershipOno Pharmaceutical partners with Aitia to hunt new brain-disease drug targets using causal AI — Dealroom09/02 16:12 JSTOno PharmaceuticalAitia
• 2026-09-02
  S2 Deal / PartnershipCurveJen and Azabu University School of Veterinary Medicine take on AMR with One Health — jointly developing an AI system that identifies bovine mastitis-causing bacteria without relying on experience — 日経バイオテクONLINE09/02 21:29 JST
• 2026-09-01
  S4 Amount disclosedDassault Systèmes to Acquire ArisGlobal for Up to $2 Billion, Integrating Life Sciences AI$2 Billion — finance.biggo.com09/01 12:26 JST
• 2026-09-01
  S3 Capital moveTempus AI pulling, refiling US antitrust paperwork for Personalis buyout — MLex09/01 06:36 JSTTempus AI
• 2026-09-01
  S2 Deal / PartnershipWeave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities — Business Wire09/01 22:00 JSTTakedaAlso reported by 1: marketscreener.com
• 2026-09-01
  S1 DeploymentSaishunkan Pharmaceutical fully adopts AI voice operator — 週刊粧業オンライン09/01 11:30 JST
• 2026-08-31
  S2 Deal / PartnershipMegazone and Hanmi Science partner to jointly develop pharmaceutical AI - CHOSUNBIZ — Chosunbiz08/31 16:00 JST
• 2026-08-30
  S2 Deal / PartnershipWhat Chugai Pharmaceutical (TSE:4519)'s Agentic AI Partnership With Phylo Means For Shareholders — webull.com08/30 12:19 JSTChugai